Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Details

Connection

Behjatolah Karbassi to Cancer Vaccines

This is a "connection" page, showing publications Behjatolah Karbassi has written about Cancer Vaccines.

 
Connection Strength
  
 
 
2.698
  
  1. Makhoul I, Hutchins L, Emanuel PD, Pennisi A, Siegel E, Jousheghany F, Monzavi-Karbassi B, Kieber-Emmons T. Moving a Carbohydrate Mimetic Peptide into the clinic. Hum Vaccin Immunother. 2015; 11(1):37-44.
    View in: PubMed
    Score: 0.464
  2. Pashov A, Monzavi-Karbassi B, Kieber-Emmons T. Immune surveillance and immunotherapy: lessons from carbohydrate mimotopes. Vaccine. 2009 May 26; 27(25-26):3405-15.
    View in: PubMed
    Score: 0.312
  3. Monzavi-Karbassi B, Hennings LJ, Artaud C, Liu T, Jousheghany F, Pashov A, Murali R, Hutchins LF, Kieber-Emmons T. Preclinical studies of carbohydrate mimetic peptide vaccines for breast cancer and melanoma. Vaccine. 2007 Apr 20; 25(16):3022-31.
    View in: PubMed
    Score: 0.271
  4. Pashov A, Monzavi-Karbassi B, Raghava G, Kieber-Emmons T. Peptide mimotopes as prototypic templates of broad-spectrum surrogates of carbohydrate antigens for cancer vaccination. Crit Rev Immunol. 2007; 27(3):247-70.
    View in: PubMed
    Score: 0.270
  5. Monzavi-Karbassi B, Pashov A, Jousheghany F, Artaud C, Kieber-Emmons T. Evaluating strategies to enhance the anti-tumor immune response to a carbohydrate mimetic peptide vaccine. Int J Mol Med. 2006 Jun; 17(6):1045-52.
    View in: PubMed
    Score: 0.259
  6. Cunto-Amesty G, Monzavi-Karbassi B, Luo P, Jousheghany F, Kieber-Emmons T. Strategies in cancer vaccines development. Int J Parasitol. 2003 May; 33(5-6):597-613.
    View in: PubMed
    Score: 0.209
  7. Pashov A, Murali R, Makhoul I, Karbassi B, Kieber-Emmons T. Harnessing Antibody Polyspecificity for Cancer Immunotherapy. Monoclon Antib Immunodiagn Immunother. 2022 Oct; 41(5):290-300.
    View in: PubMed
    Score: 0.201
  8. Monzavi-Karbassi B, Cunto-Amesty G, Luo P, Kieber-Emmons T. Use of surrogate antigens as vaccines against cancer. Hybrid Hybridomics. 2002 Apr; 21(2):103-9.
    View in: PubMed
    Score: 0.194
  9. Monzavi-Karbassi B, Kieber-Emmons T. Current concepts in cancer vaccine strategies. Biotechniques. 2001 Jan; 30(1):170-2, 174, 176 passim.
    View in: PubMed
    Score: 0.178
  10. Kieber-Emmons T, Monzavi-Karbassi B, Hutchins LF, Pennisi A, Makhoul I. Harnessing benefit from targeting tumor associated carbohydrate antigens. Hum Vaccin Immunother. 2017 02; 13(2):323-331.
    View in: PubMed
    Score: 0.136
  11. Pashov A, Monzavi-Karbassi B, Kieber-Emmons T. Glycan mediated immune responses to tumor cells. Hum Vaccin. 2011 Jan-Feb; 7 Suppl:156-65.
    View in: PubMed
    Score: 0.089
  12. Pashov A, Monzavi-Karbassi B, Chow M, Cannon M, Kieber-Emmons T. Immune surveillance as a rationale for immunotherapy? Hum Vaccin. 2007 Sep-Oct; 3(5):224-8.
    View in: PubMed
    Score: 0.069
  13. Monzavi-Karbassi B, Cunto-Amesty G, Luo P, Shamloo S, Blaszcyk-Thurin M, Kieber-Emmons T. Immunization with a carbohydrate mimicking peptide augments tumor-specific cellular responses. Int Immunol. 2001 Nov; 13(11):1361-71.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.